Table 1.
Coculture (ratio) | Total number of cells/well | CD4+ (% in total number of cells) | CD4+CD25+ (% in CD4+) | Tregs | Ratio effector cells:Tregs | |
---|---|---|---|---|---|---|
(% in CD4+) | (% in CD4+CD25+) | |||||
CD4+ : CD40L- treated DCs (10:1) | 2.65 × 106 | 2.41 × 106 (91.2%) | 2.12 × 105 (8.8%) | 0.86 × 105 (3.5%) | 40.3% | 1.5:1 |
CD4+ : YEAST- treated DCs (10:1) | 3.50 × 106 | 3.10 × 106 (88.8%) | 3.59 × 105 (11.6%) | 1.10 × 105 (4.4%) | 30.6% | 2.4:1 |
CD4+ : CD40L- treated DCs (5:1) | 2.81 × 106 | 2.50 × 106 (89.3%) | 2.12 × 105 (8.5%) | 1.10 × 105 (3.4%) | 51.8% | 0.9:1 |
CD4+ : YEAST- treated DCs (5:1) | 4.12 × 106 | 3.53 × 106 (85.7%) | 6.81 × 105 (19.3%) | 1.41 × 105 (4.0%) | 20.7% | 3.8:1 |
Tregs = CD4+CD25+CD127−FoxP3+
Effector cells = CD4+CD25+
DCs were treated with yeast at a yeast:DC ratio of 10:1 for 48 h or with CD40L (1 μg/ml) for 24 h. Isolated autologous CD4+ T cells were cocultured with yeast-treated DCs or CD40L-treated DCs at 2 ratios (10:1 or 5:1). FACS analysis was performed on day 5.
Ratio of effector cells:Tregs = ([CD4+CD25+] - [CD4+CD25+CD127-FoxP3+Tregs]/[CD4+CD25+CD127-FoxP3+Tregs]).
HD = healthy donor.